• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌源于黏膜场效应。

The origin of bladder cancer from mucosal field effects.

作者信息

Bondaruk Jolanta, Jaksik Roman, Wang Ziqiao, Cogdell David, Lee Sangkyou, Chen Yujie, Dinh Khanh Ngoc, Majewski Tadeusz, Zhang Li, Cao Shaolong, Tian Feng, Yao Hui, Kuś Paweł, Chen Huiqin, Weinstein John N, Navai Neema, Dinney Colin, Gao Jianjun, Theodorescu Dan, Logothetis Christopher, Guo Charles C, Wang Wenyi, McConkey David, Wei Peng, Kimmel Marek, Czerniak Bogdan

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Systems Biology and Engineering and Biotechnology Centre, Silesian University of Technology, Gliwice, Poland.

出版信息

iScience. 2022 Jun 7;25(7):104551. doi: 10.1016/j.isci.2022.104551. eCollection 2022 Jul 15.

DOI:10.1016/j.isci.2022.104551
PMID:35747385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9209726/
Abstract

Whole-organ mapping was used to study molecular changes in the evolution of bladder cancer from field effects. We identified more than 100 dysregulated pathways, involving immunity, differentiation, and transformation, as initiators of carcinogenesis. Dysregulation of interleukins signified the involvement of inflammation in the incipient phases of the process. An aberrant methylation/expression of multiple genes signified dysregulation of the differentiation program. We identified three types of mutations based on their geographic distribution. The most common were mutations restricted to individual mucosal samples that targeted uroprogenitor cells. Two types of mutations were associated with clonal expansion and involved large areas of mucosa. The α mutations occurred at low frequencies while the β mutations increased in frequency with disease progression. Modeling revealed that bladder carcinogenesis spans 10-15 years and can be divided into dormant and progressive phases. The progressive phase lasted 1-2 years and was driven by β mutations.

摘要

全器官图谱被用于研究膀胱癌从场效应演变过程中的分子变化。我们鉴定出100多条失调的信号通路,涉及免疫、分化和转化,这些是致癌作用的起始因素。白细胞介素的失调表明炎症参与了该过程的初始阶段。多个基因的异常甲基化/表达表明分化程序失调。我们根据其地理分布鉴定出三种类型的突变。最常见的是局限于靶向尿路上皮祖细胞的单个黏膜样本的突变。两种类型的突变与克隆性扩增相关,累及大面积黏膜。α突变发生频率较低,而β突变随疾病进展频率增加。建模显示,膀胱癌发生过程持续10 - 15年,可分为休眠期和进展期。进展期持续1 - 2年,由β突变驱动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8220fb12e7db/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/1ded186acc6f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/0501bcacacb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8a363f9dab70/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/991aed0033d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/b89d369931fa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/35caeac472d3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8ed9bea68e58/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/008b6ce29321/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8220fb12e7db/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/1ded186acc6f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/0501bcacacb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8a363f9dab70/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/991aed0033d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/b89d369931fa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/35caeac472d3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8ed9bea68e58/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/008b6ce29321/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b6/9209726/8220fb12e7db/gr8.jpg

相似文献

1
The origin of bladder cancer from mucosal field effects.膀胱癌源于黏膜场效应。
iScience. 2022 Jun 7;25(7):104551. doi: 10.1016/j.isci.2022.104551. eCollection 2022 Jul 15.
2
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.通过全器官空间突变、蛋白质组学和代谢组学图谱从黏膜场效应推断膀胱癌的演变
Res Sq. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376/v1.
3
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.全器官基因组特征分析揭示了启动膀胱癌发生的黏膜场效应。
Cell Rep. 2019 Feb 19;26(8):2241-2256.e4. doi: 10.1016/j.celrep.2019.01.095.
4
Genetic modeling of human urinary bladder carcinogenesis.人类膀胱癌发生的遗传建模
Genes Chromosomes Cancer. 2000 Apr;27(4):392-402.
5
[Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].[膀胱癌中的点体细胞突变:关键致癌事件、诊断标志物及治疗靶点]
Urologiia. 2016 Feb(1):100-105.
6
Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia.RB1附近参与原位尿路上皮肿瘤克隆性扩增的其他候选基因的证据。
Lab Invest. 2006 Feb;86(2):175-90. doi: 10.1038/labinvest.3700378.
7
The origins of bladder cancer.膀胱癌的起源。
Lab Invest. 2008 Jul;88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12.
8
Origins of Bladder Cancer.膀胱癌的起源。
Annu Rev Pathol. 2016 May 23;11:149-74. doi: 10.1146/annurev-pathol-012513-104703. Epub 2016 Feb 22.
9
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.LPAR6 和 CAB39L 的缺失会扰乱基底到腔上皮的尿路上皮分化程序,导致膀胱癌的发生。
Cell Rep. 2024 May 28;43(5):114146. doi: 10.1016/j.celrep.2024.114146. Epub 2024 Apr 25.
10
Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression.膀胱癌进展相关的5号染色体区域的图谱绘制与基因组序列分析
Lab Invest. 2001 Jul;81(7):1039-48. doi: 10.1038/labinvest.3780315.

引用本文的文献

1
Mechanisms and implications of epithelial cell plasticity in the bladder.膀胱上皮细胞可塑性的机制及影响
Nat Rev Urol. 2025 Jul 24. doi: 10.1038/s41585-025-01066-y.
2
What spatial omics is teaching us about field cancerisation in prostate and bladder cancer.空间组学在前列腺癌和膀胱癌的场癌化方面教给我们的知识。
BJU Int. 2025 Jun 25. doi: 10.1111/bju.16830.
3
Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer.预测高危非肌层浸润性膀胱癌对卡介苗的反应

本文引用的文献

1
The Parsimony Ratchet, a New Method for Rapid Parsimony Analysis.简约棘轮法:一种快速简约分析的新方法。
Cladistics. 1999 Dec;15(4):407-414. doi: 10.1111/j.1096-0031.1999.tb00277.x.
2
CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.CRTAC1(软骨酸性蛋白 1)通过下调 Yin Yang 1(YY1)使 TGF-β 通路失活,抑制膀胱癌中的细胞增殖、迁移、侵袭和上皮间质转化(EMT)过程。
Bioengineered. 2021 Dec;12(2):9377-9389. doi: 10.1080/21655979.2021.1974645.
3
Transl Cancer Res. 2024 Nov 30;13(11):6489-6502. doi: 10.21037/tcr-24-180. Epub 2024 Jul 30.
4
Imposter among us: field cancerization in the bladder.我们之中的冒名顶替者:膀胱中的场癌化
Transl Androl Urol. 2024 Jul 31;13(7):1319-1323. doi: 10.21037/tau-24-8. Epub 2024 Jul 4.
5
What is a Bladder Cancer Molecular Subtype? - Counterpoint.什么是膀胱癌分子亚型?——对立观点。
Bladder Cancer. 2023 Dec 13;9(4):299-304. doi: 10.3233/BLC-230059. eCollection 2023.
6
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.LPAR6 和 CAB39L 的缺失会扰乱基底到腔上皮的尿路上皮分化程序,导致膀胱癌的发生。
Cell Rep. 2024 May 28;43(5):114146. doi: 10.1016/j.celrep.2024.114146. Epub 2024 Apr 25.
7
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.通过全器官空间突变、蛋白质组学和代谢组学图谱从黏膜场效应推断膀胱癌的演变
Res Sq. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376/v1.
8
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer.基于 MRI/RNA-Seq 的放射基因组学和人工智能在肌肉浸润性膀胱癌更准确分期中的应用。
Int J Mol Sci. 2023 Dec 20;25(1):88. doi: 10.3390/ijms25010088.
9
The urothelial gene regulatory network: understanding biology to improve bladder cancer management.尿路上皮基因调控网络:通过理解生物学原理改善膀胱癌治疗
Oncogene. 2024 Jan;43(1):1-21. doi: 10.1038/s41388-023-02876-3. Epub 2023 Nov 23.
10
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma.
CEACAM7 是胰腺导管腺癌 CAR T 细胞治疗的有效靶点。
Clin Cancer Res. 2021 Mar 1;27(5):1538-1552. doi: 10.1158/1078-0432.CCR-19-2163. Epub 2021 Jan 21.
4
Bladder Tumor Subtype Commitment Occurs in Carcinoma Driven by Key Signaling Pathways Including ECM Remodeling.膀胱癌亚型的形成与关键信号通路有关,包括细胞外基质重塑,这些通路驱动了癌的发生。
Cancer Res. 2021 Mar 15;81(6):1552-1566. doi: 10.1158/0008-5472.CAN-20-2336. Epub 2021 Jan 20.
5
Expression of CDK13 Was Associated with Prognosis and Expression of HIF-1α and beclin1 in Breast Cancer Patients.CDK13的表达与乳腺癌患者的预后以及HIF-1α和beclin1的表达相关。
J Invest Surg. 2022 Feb;35(2):442-447. doi: 10.1080/08941939.2020.1852344. Epub 2020 Dec 8.
6
Overexpression of MicroRNA 142-5p Suppresses the Progression of Cervical Cancer through Targeting Phosphoinositol-3-Kinase Adaptor Protein 1 Expression.MicroRNA 142-5p 的过表达通过靶向磷酸肌醇 3-激酶衔接蛋白 1 的表达抑制宫颈癌的进展。
Mol Cell Biol. 2021 May 21;41(6):e0036320. doi: 10.1128/MCB.00363-20.
7
MLLT6 maintains PD-L1 expression and mediates tumor immune resistance.MLLT6 维持 PD-L1 的表达并介导肿瘤免疫抵抗。
EMBO Rep. 2020 Dec 3;21(12):e50155. doi: 10.15252/embr.202050155. Epub 2020 Oct 15.
8
Macroscopic somatic clonal expansion in morphologically normal human urothelium.形态正常的人尿路上皮中的巨观体体细胞克隆扩增。
Science. 2020 Oct 2;370(6512):82-89. doi: 10.1126/science.aba7300.
9
Extensive heterogeneity in somatic mutation and selection in the human bladder.人类膀胱中体细胞突变和选择的广泛异质性。
Science. 2020 Oct 2;370(6512):75-82. doi: 10.1126/science.aba8347.
10
BAP1: Not just a BRCA1-associated protein.BAP1:不只是一个与 BRCA1 相关的蛋白。
Cancer Treat Rev. 2020 Nov;90:102091. doi: 10.1016/j.ctrv.2020.102091. Epub 2020 Aug 20.